National Comprehensive Cancer Network



About NCCN

Neuroendocrine Tumors Panel - Disclosures as of 5/19/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Al B. Benson III, MD, FACP

Abbott Laboratories;
Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Alchemia;
gilead;
Infinity

Agendia BV;
Bayer HealthCare;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
National Cancer Institute;
Precision Therapeutics, Inc.

None

None

8/31/2012

Emily Bergsland, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Lexicon;
sanofi-aventis U.S.

Novartis Pharmaceuticals Corporation

None

None

10/14/2012

Jordan D. Berlin, MD

Abbott Laboratories;
Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
ImClone Systems Incorporated;
Novartis Pharmaceuticals Corporation;
Pfizer

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Eli Lilly and Company;
Novartis Pharmaceuticals Corporation;
symphogen;
Roche Laboratories, Inc.

None

None

12/9/2012

Lawrence S. Blaszkowsky, MD

Genentech, Inc.;
GlaxoSmithKline

None

None

None

9/28/2011

Michael A. Choti, MD, MBA

None

Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

2/12/2013

Orlo H. Clark, MD

Xoma

Xoma

None

None

3/8/2013

Mary Dwyer, MS

None

None

None

None

3/26/2013

Lyska Emerson, MD

None

None

None

None

8/9/2012

Paul F. Engstrom, MD, FACP

None

None

None

None

2/27/2013

Deborah Freedman-Cass, PhD

None

None

None

None

3/7/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Whitney S. Goldner, MD

None

None

None

None

11/14/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Martin J. Heslin, MD

None

None

None

None

10/8/2012

Fouad Kandeel, MD, PhD

None

None

None

None

8/17/2012

Matthew H. Kulke, MD

None

Novartis Pharmaceuticals Corporation;
Ipsen;
Lexicon;
Pfizer Inc.

None

None

8/9/2012

Pamela L. Kunz, MD

Genentech, Inc.;
Merck & Co., Inc.;
sanofi-aventis U.S.

None

None

None

9/3/2012

Boris W. Kuvshinoff, MD, MBA

None

None

None

None

10/24/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Jeffrey F. Moley, MD

AstraZeneca Pharmaceuticals LP;
Exelixis Inc.

Exelixis Inc.

None

None

10/8/2012

Gitonga Munene, MD

       

Pending

Venu G. Pillarisetty, MD

None

None

None

None

8/16/2012

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Taiho Parmaceuticals Co., Ltd.

None

None

8/27/2012

David E. Schteingart, MD

Corcept Therapeutics

None

None

None

4/9/2012

Manisha H. Shah, MD

National Cancer Institute;
Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

None

None

8/20/2012

Jonathan R. Strosberg, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

11/9/2012

Jean-Nicolas Vauthey, MD

None

None

None

None

9/13/2012

Rebekah White, MD

None

None

None

None

2/3/2012

James C. Yao, MD

Genentech, Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Ipsen;
Lexicon

National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

11/28/2012